Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ESMO 2016 /
Biomarkers of sensitivity and resistance

7th - 11th Oct 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 26.10.16
Views: 1617
Rating:

Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Dr Seoane talks to ecancertv at ESMO 2016 about modelling cell lines and determining biomarkers for better prognosis.

Considering the pathways through which cancers develop insenstivity to different therapies, Dr Seoane highlights the need for greater understanding and proactive prevention of resistance with novel treatments and combination therapy.

Dr Cristina Cruz also spoke with ecancer about resistance to PARP inhibitors here.

 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation